olmesartan has been researched along with Overweight in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Batista, GMS; Campos, MO; Garcia, VP; Gomes, EAC; Mentzinger, J; Nóbrega, ACL; Rocha, HNM; Rocha, NG; Storch, AS; Teixeira, GF | 1 |
Davy, BM; Davy, KP; Frisard, MI; Hulver, MW; Marinik, EL; Rivero, JM; Savla, JS | 1 |
1 trial(s) available for olmesartan and Overweight
Article | Year |
---|---|
Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.
Topics: Angiotensin Receptor Antagonists; Biopsy; Cross-Over Studies; Female; Glucose Tolerance Test; Humans; Hypertension; Imidazoles; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Obesity; Overweight; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2013 |
1 other study(ies) available for olmesartan and Overweight
Article | Year |
---|---|
AT1R blocker prevents mental stress induced retrograde blood flow in overweight/obese men.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Brachial Artery; Endothelium, Vascular; Humans; Male; Nitrites; Obesity; Overweight; Regional Blood Flow; Stress, Psychological; Vasodilation; Young Adult | 2023 |